FS-Elliott Company Profile

21:07 EDT 21st October 2018 | BioPortfolio

FS-Elliott is a global leader in the engineering and manufacturing of oil-free, centrifugal air compressors with operations in over 90 countries. Building on a 50-year tradition of excellence, FS-Elliott combines an unwavering commitment to quality with the desire for advancing technology to bring value to our customers, allowing them to increase their productivity and lower system operating costs. For more information, please visit

News Articles [27 Associated News Articles listed on BioPortfolio]

Elliott Management Outlines Concerns With athenahealth’s Lack of Engagement Over Acquisition Bid in Letter

On Tuesday, Elliott Management Corporation (“Elliott”) released a letter to the Board of Directors of athenahealth, Inc. regarding Elliott’s proposal to acquire athenahealth for $160 per share ...

Elliott Squires is recognized by Continental Who's Who

GREENVILLE, N.C., April 2, 2018/PRNewswire/ -- Elliott Squiresis recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Read more...

Dellann Elliott Mydland, President of the EndBrainCancer Initiative, to Serve on Two National Clinical Trial Committees for NRG Oncology, an NCI-Funded Research Group

SEATTLE (PRWEB) August 29, 2018 Dellann Elliott Mydland, President and co-founder of the EndBrainCancer Initiative (EBCI), formerly ...

Will athenahealth accept Elliott Management’s hefty buyout offer?

After Elliott Management sent a third letter to athenahealth urging it to consider the offer, the EHR vendor retorted with a statement of its own, noting it will take its time in evaluating the bid.

Elliott Management Makes $7 Billion Takeover Offer for athenahealth

Investment firm Elliott Management has proposed acquiring Watertown, Mass.-based health IT vendor athenahealth in a deal worth nearly $7 billion.

Activist investor Elliott Management makes $6.9B unsolicited offer for athenahealth

In a letter to athenahealth’s board of directors, Elliott Management Partner Jesse Cohn makes his firm’s case for why the company would be better off as a private business.

Sempra Energy Announces Agreement With Elliott Management And Bluescape Energy

SAN DIEGO, Sept. 18, 2018 /PRNewswire/ -- Sempra Energy (NYSE: SRE) today announced that it has entered into a cooperation agreement with affiliates of Elliott Read more...

Elliott makes $7B all-cash bid for Athenahealth

Elliott makes $7B all-cash bid for Athenahealth nleider Mon, 05/07/2018 - 14:44 Teaser Media

Drugs and Medications [0 Results]


PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Correction to: Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future.

In the original version of this article, author Ryan Elliott's name was misspelled as Ryan Eliott. The correct spelling of the name is Ryan Elliott.

Dr. elliot f. ellis: initiating personalized asthma management in children.

Elliot F. Ellis is indeed a giant in the field of allergy and immunology. From his leadership role in developing a pediatric allergy and immunology fellowship at National Jewish Health and his seminal...

Testing the effects of explicit and implicit bidimensional attitudes on objectively measured speeding behaviour.

Bidimensional attitudes have been shown to independently predict behaviour, with the positive dimension of attitude being a stronger predictor of behaviour than the negative dimension (e.g., Elliott, ...

Occupancy and detectability modelling of vertebrates in northern Australia using multiple sampling methods.

Understanding where species occur and how difficult they are to detect during surveys is crucial for designing and evaluating monitoring programs, and has broader applications for conservation plannin...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Brain Development Research Program

Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of...

A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)

A multi-center, placebo controlled, double-blind trial comparing the efficacy and safety of 18 months of treatment with deferiprone versus placebo in patients with PKAN. This investigator...

Companies [8 Associated Companies listed on BioPortfolio]


FS-Elliott is a global leader in the engineering and manufacturing of oil-free, centrifugal air compressors with operations in over 90 countries. Building on a 50-year tradition o...

David Elliott

Elliott Advisors

David Elliott Healing

Elliott Management Corporation

More Information about "FS-Elliott" on BioPortfolio

We have published hundreds of FS-Elliott news stories on BioPortfolio along with dozens of FS-Elliott Clinical Trials and PubMed Articles about FS-Elliott for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FS-Elliott Companies in our database. You can also find out about relevant FS-Elliott Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record